[Corrections] Correction to Lancet Infect Dis 2024; published online Oct 10. https://doi.org/10.1016/S1473-3099(24)00507-3

Di |2024-11-05T00:30:03+01:00Novembre 5th, 2024|Categorie: Coronavirus Lancet|

Babiker A, Warner S, Li X, et al. Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target t...

[Corrections] Correction to Lancet Infect Dis 2024; published online Oct 10. https://doi.org/10.1016/S1473-3099(24)00507-3

Di |2024-11-05T00:30:03+01:00Novembre 5th, 2024|Categorie: Coronavirus Lancet|

Babiker A, Warner S, Li X, et al. Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target t...

[Articles] Evaluating culture-free targeted next-generation sequencing for diagnosing drug-resistant tuberculosis: a multicentre clinical study of two end-to-end commercial workflows

Di |2024-10-30T00:30:06+01:00Ottobre 30th, 2024|Categorie: Coronavirus Lancet|

This multicentre evaluation demonstrates that culture-free tNGS can provide accurate sequencing results for detection and characterisation of drug resistance from Mycobacterium tuberculosis clinical sediment samples for timely, comprehensive profiling ...

[Comment] The promise and the reality of targeted next-generation sequencing for drug-resistant tuberculosis detection

Di |2024-10-30T00:30:02+01:00Ottobre 30th, 2024|Categorie: Coronavirus Lancet|

The ability to sequence the Mycobacterium tuberculosis genome represents the biggest microbiological advance since Robert Koch identified it as the causative agent of tuberculosis. Routine whole-genome sequencing (WGS) has been implemented in some coun...

[Correspondence] Predictable excess hepatotoxicity in the SimpliciTB trial – Authors’ reply

Di |2024-10-29T00:30:01+01:00Ottobre 29th, 2024|Categorie: Coronavirus Lancet|

William Burman and colleagues suggest that the hepatotoxicity of the bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) regimen observed in the SimpliciTB trial1 was predictable from the liver-related treatment emergent adverse events repo...

[Correspondence] Predictable excess hepatotoxicity in the SimpliciTB trial – Authors’ reply

Di |2024-10-29T00:30:01+01:00Ottobre 29th, 2024|Categorie: Coronavirus Lancet|

William Burman and colleagues suggest that the hepatotoxicity of the bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) regimen observed in the SimpliciTB trial1 was predictable from the liver-related treatment emergent adverse events repo...

[Articles] Serotype-specific epidemiological patterns of inapparent versus symptomatic primary dengue virus infections: a 17-year cohort study in Nicaragua

Di |2024-10-26T00:30:01+02:00Ottobre 26th, 2024|Categorie: Coronavirus Lancet|

Our study indicates that case surveillance skews the perceived epidemiological footprint of DENV. We reveal a more complex and intricate pattern of serotype distribution in inapparent infections. The substantial differences in infection outcomes by ser...

Torna in cima